|

Stepwise Withdrawal of ARNI and SGLT2i Clinical Trials

1 actively recruiting trial

Pipeline

Phase 4: 1

Top Sponsors

  • Kyungsub Song1

Indications

  • Ventricular Dysfunction, Left1
  • Heart Failure With Reduced Ejection Fraction1
  • Heart Disease1
  • Heart Failure1

Other1 trial

STEPwise De-escalation and Optimizing Withdrawal of ARNI and SGLT2i in Normalized Heart Failure
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.